Ambeed.cn

首页 / 抑制剂/激动剂 / 膜转运蛋白 / 钠通道 / A-803467

A-803467 {[allProObj[0].p_purity_real_show]}

货号:A630517

A-803467是一种选择性 NaV1.8 钠通道阻断剂,IC50 为 8 nM,适用于神经性疼痛和炎症性疼痛研究,选择性高于其他 NaV 通道 100 倍以上。

A-803467 化学结构 CAS号:944261-79-4
A-803467 化学结构
CAS号:944261-79-4
A-803467 3D分子结构
CAS号:944261-79-4
A-803467 化学结构 CAS号:944261-79-4
A-803467 3D分子结构 CAS号:944261-79-4
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

A-803467 纯度/质量文件 产品仅供科研

货号:A630517 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Sodium Channel 其他靶点 纯度
Tolperisone HCl 99%
Triamterene +++

ENaC, IC50: 4.5 μM

98%
Lamotrigine 98%
Vinpocetine 98%
Zonisamide 99%
Dronedarone HCl 95%
Procainamide HCl 99%
Bupivacaine HCl 99+%
Benzocaine 98%
Carbamazepine ++

Sodium channel, IC50: 131 μM

98%
Quinidine sulfate dihydrate 98%
Ibutilide fumarate 99%+
Dibucaine HCl 99+%
Mexiletine HCl 99%
Phenytoin 99+%
Camostat Mesylate +++

epithelial sodium channel (ENaC), IC50: 50 nM

99%+
Levobupivacaine 97+%
Oxcarbazepine +

sodium channel, IC50: 160 μM

98%
Amiloride HCl dihydrate 97%
Ambroxol 98+%
Primidone 99%
Propafenone 99%
A-803467 ++++

Na(V1.8) channel, IC50: 8 nM

99%+
Rufinamide 99%
Phenytoin sodium 98%
Proparacaine HCl +

Voltage-gated sodium channel, ED50: 3.4 mM

98+%
Amiloride HCl 98%
Riluzole 97%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

A-803467 生物活性

靶点
  • Sodium Channel

    Na(V1.8) channel, IC50:8 nM

描述 A-803467 is a potent and selective tetrodotoxin-resistant Nav1.8 sodium channel blocker (IC50=8 nM). A-803467 (20 mg/kg, i.v.) blocked mechanically evoked firing of wide dynamic range neurons in the rat spinal dorsal horn. A-803467 also dose-dependently reduced mechanical allodynia in a variety of rat pain models including: spinal nerve ligation (ED(50) = 47 mg/kg, i.p.), sciatic nerve injury (ED(50) = 85 mg/kg, i.p.), capsaicin-induced secondary mechanical allodynia (ED(50) approximately 100 mg/kg, i.p.), and thermal hyperalgesia after intraplantar complete Freund's adjuvant injection (ED(50) = 41 mg/kg, i.p.)[3]. A-803467 selectively and significantly reverses the ABCG2-mediated multidrug resistance. A-803467 (7.5 μM) significantly increased the intracellular accumulation of [(3)H]-mitoxantrone by inhibiting the transport activity of ABCG2, without altering its expression levels. In addition, A-803467 stimulated the ATPase activity in membranes overexpressed with ABCG2. In a murine model system, combination treatment of A-803467 (35 mg/kg) and topotecan (3 mg/kg) significantly inhibited the tumor growth in mice xenografted with ABCG2-overexpressing cancer cells[4]. A-803467 significantly shortened ventricular effective refractory period, APD90, and ventricular fibrillation threshold compared to control. In the A-803467 group, the incidence of ventricular arrhythmias was significantly higher compared to control. A-803467 suppressed the slowing of heart rate response to high-frequency electrical stimulation of the anterior right GP(ganglionated plexi), suggesting that A-803467 could inhibit GP activity[5].

A-803467 细胞实验

Cell Line
Concentration Treated Time Description References
HEK cells 8 nM A-803467 inhibited inward currents in HEK cells Arthritis Res Ther. 2012 Jan 7;14(1):R5.
ND7/23 cells 30 nM Evaluate the selective inhibition of Nav1.8 current by A-803467 Circ Res. 2012 Jul 20;111(3):322-32.
HEK-293 cells 8 nM Block human Nav1.8 channels Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5.
GH3 cells 3 µM Suppressed the peak density of voltage-gated Na+ current (INa) Int J Mol Sci. 2020 Mar 31;21(7):2416.
Human hypertrophic cardiomyocytes 30 nM 10 min Significantly reduced the persistent Na+ current (INaL), shortened action potential duration, and decreased sarcoplasmic reticulum Ca2+ leak ESC Heart Fail. 2019 Feb;6(1):154-163.
Human atrial cardiomyocytes 30 nM 15 minutes To investigate the effect of NaV1.8 inhibition on late sodium current, results showed A-803467 significantly reduced late sodium current. Basic Res Cardiol. 2020 Feb 20;115(2):20.
Small-sized DRG neurons 5 µM Used to block Nav1.8 currents and confirm the modulation effect of BmK I on Nav1.8 Protein Cell. 2015 Jun;6(6):443-52.
Rat dorsal root ganglion neurons 140 nM Block TTX-R currents and inhibit action potential generation Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5.
ND-7/23 cells 0.73±0.08 µM (IC50) Determination of the half-maximal inhibitory concentration (IC50) of A-803467 on Na v1.8 Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2208211119.
TSA201 cells 100 nM To investigate the electrophysiological effects of A-803467 on SCN10A-SCN5A-SCN3B co-transfected TSA201 cells. Results showed that A-803467 significantly reduced INa,P and INa,L and altered channel kinetics. J Am Heart Assoc. 2016 Nov 2;5(11):e004050.
Mouse dorsal root ganglion neurons 500 nM A-803467 blocked repetitive action potential firing in DRG neurons of both HDC−/− and wild-type mice. CNS Neurosci Ther. 2013 Sep;19(9):649-58.
Mouse dorsal root ganglion neurons 300 nM A-803467 selectively blocked Nav1.8 channels, reduced the excitability of DRG neurons in HDC−/− mice, and blocked repetitive action potential firing. CNS Neurosci Ther. 2013 Sep;19(9):649-58.
Ventricular myocytes 100 nM To evaluate the effect of Nav1.8 inhibitor A-803467 on INa,Late, results showed no significant effect of A-803467 on INa,Late Int J Mol Sci. 2022 May 20;23(10):5735.

A-803467 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Dogs Acute atrial fibrillation model Injection into ganglionated plexi 1 μmol/0.5 mL per GP Single injection followed by 6-hour rapid atrial pacing To evaluate the effect of A-803467 on an acute atrial fibrillation model. Results showed that A-803467 significantly reduced the incidence of AF, shortened AF duration, and prolonged AF cycle length. J Am Heart Assoc. 2016 Nov 2;5(11):e004050.
Canine Acute ischemia-induced ventricular arrhythmia model Left stellate ganglion injection 10 mM, 15 mM, 20 mM Single injection Blocking the Nav1.8 channel could significantly attenuate ischemia-induced VA, primarily by suppressing LSG activity Sci Rep. 2017 Apr 3;7(1):534
Sprague-Dawley rats Sciatic nerve transection-repair model Infusion around the injured site 10 μM For 3 days A-803467 significantly attenuated Nav1.8 upregulation after sciatic nerve transection and promoted axon regeneration. Anesthesiology. 2023 Dec 1;139(6):782-800
Mice Wild-type mice Intraperitoneal injection 25 mg/kg Single dose, recorded for 45 minutes To validate the role of NaV1.8 in the cardiac response to atropine. Results showed that the heart rate response to atropine was significantly lower in wild-type mice after A-803467 treatment. Front Pharmacol. 2020 Jul 31;11:1163
Rats Neuropathic pain model (L5/L6 spinal nerve injury) Intraperitoneal injection 47 mg/kg Single dose Reduce mechanical allodynia Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5.
Wistar rats Osteoarthritis model Intra-arterial injection 500 μg Single injection A-803467 significantly reduced the firing rate of joint afferents during noxious rotation of the joint but had no effect during non-noxious rotation. In the pain studies, peripheral injection of A-803467 into OA knees attenuated hindlimb incapacitance and secondary allodynia. Arthritis Res Ther. 2012 Jan 7;14(1):R5.

A-803467 参考文献

[1]Joshi SK, Honore P, et al. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models. J Pain. 2009 Mar;10(3):306-15.

[2]Jarvis MF, Honore P, et al. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5. Epub 2007 May 2.

[3]Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, Thomas J, Liu D, Krambis M, Liu Y, McGaraughty S, Chu K, Roeloffs R, Zhong C, Mikusa JP, Hernandez G, Gauvin D, Wade C, Zhu C, Pai M, Scanio M, Shi L, Drizin I, Gregg R, Matulenko M, Hakeem A, Gross M, Johnson M, Marsh K, Wagoner PK, Sullivan JP, Faltynek CR, Krafte DS. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A. 2007 May 15;104(20):8520-5

[4]Anreddy N, Patel A, Zhang YK, Wang YJ, Shukla S, Kathawala RJ, Kumar P, Gupta P, Ambudkar SV, Wurpel JN, Chen ZS, Guo H. A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo. Oncotarget. 2015 Nov 17;6(36):39276-91

[5]Qi B, Dai S, Song Y, Shen D, Li F, Wei L, Zhang C, Nie Z, Lin J, Cai L, Ge J. Blockade of NaV1.8 Increases the Susceptibility to Ventricular Arrhythmias During Acute Myocardial Infarction. Front Cardiovasc Med. 2021 Aug 2;8:708279

A-803467 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.79mL

0.56mL

0.28mL

13.97mL

2.79mL

1.40mL

27.95mL

5.59mL

2.79mL

A-803467 技术信息

CAS号944261-79-4
分子式C19H16ClNO4
分子量 357.79
SMILES Code O=C(C1=CC=C(C2=CC=C(Cl)C=C2)O1)NC3=CC(OC)=CC(OC)=C3
MDL No. MFCD10574689
别名
运输蓝冰
InChI Key VHKBTPQDHDSBSP-UHFFFAOYSA-N
Pubchem ID 16038374
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 50 mg/mL(139.75 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。